BioNTech SE (BNTX) Long-Term Deferred Tax (2020 - 2025)

BioNTech SE (BNTX) has 6 years of Long-Term Deferred Tax data on file, last reported at $15.7 million in Q4 2025.

• In Q4 2025, Long-Term Deferred Tax fell 82.0% year-over-year to $15.7 million; the TTM figure through Dec 2025 stood at $15.7 million (down 82.0% YoY), while the FY2025 annual figure was $15.3 million, down 82.53% from the prior year.
• Long-Term Deferred Tax slipped to $15.7 million in Q4 2025, from $20.7 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $346.5 million in Q3 2022 and bottomed at $15.7 million in Q4 2025.
• A 5-year average of $146.7 million and a median of $99.6 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2024 — Long-Term Deferred Tax slipped 0.19% — and 2025, when it sank 82.0%.
• Year by year, Long-Term Deferred Tax stood at $170.9 million in 2021, then soared by 37.05% to $234.2 million in 2022, then sank by 62.66% to $87.5 million in 2023, then fell by 0.19% to $87.3 million in 2024, then sank by 82.0% to $15.7 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $15.7 million (Q4 2025), $20.7 million (Q3 2025), and $88.1 million (Q2 2025), per Business Quant data.

Peer Comparison